プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
mielosupresie
myelosuppression
最終更新: 2017-04-26
使用頻度: 3
品質:
mielosupresie/neutropenie
myelosuppression/neutropenia
最終更新: 2017-04-26
使用頻度: 1
品質:
basiliximab nu provoacă mielosupresie.
basiliximab does not cause myelosuppression.
最終更新: 2017-04-26
使用頻度: 3
品質:
toţi pacienţii au prezentat mielosupresie marcată.
all patients experienced a profound myelosuppression.
最終更新: 2017-04-26
使用頻度: 1
品質:
infecţii şi afecţiuni maligne care determină mielosupresie
infections and malignancies causing myelosuppression
最終更新: 2017-04-26
使用頻度: 1
品質:
poate apărea o mielosupresie în formă severă.
severe myelosuppression may occur.
最終更新: 2017-04-26
使用頻度: 1
品質:
mielosupresie (inclusiv anemie, neutropenie, trombocitopenie)
myelosuppression (including anaemia, neutropaenia, thrombocytopaenia)
最終更新: 2017-04-26
使用頻度: 1
品質:
nu s-au semnalat manifestări de mielosupresie cumulativă.
no evidence of cumulative myelosuppression was observed.
最終更新: 2017-04-26
使用頻度: 3
品質:
insuficienţă renală sau hepatică severă şi mielosupresie severă
severe renal or hepatic failure and severe myelosuppression
最終更新: 2017-04-26
使用頻度: 1
品質:
exemplu tromboflebită, embolie pulmonară) sau mielosupresie severă.
pulmonary embolism) or severe myelosuppression.
最終更新: 2012-04-11
使用頻度: 2
品質:
majoritatea pacienţilor au continuat tratamentul fără dovezi ulterioare de mielosupresie.
most patients continued treatment without further evidence of myelosuppression.
最終更新: 2017-04-26
使用頻度: 3
品質:
principalul efect toxic se manifestă la nivelul măduvei hematogene, determinând mielosupresie.
the principal toxic effect is on the bone marrow, resulting in myelosuppression.
最終更新: 2017-04-26
使用頻度: 1
品質:
1 pe baza evaluărilor de laborator: grad maximal de mielosupresie (populație tratată)
1 based on laboratory assessments: maximal degree of myelosuppression (treated population)
最終更新: 2017-04-26
使用頻度: 1
品質:
64 reacţii adverse importante mielosupresie: tratamentul cu dasatinib este asociat cu anemie, neutropenie şi trombocitopenie.
important adverse reactions myelosuppression: treatment with dasatinib is associated with anaemia, neutropenia and thrombocytopenia.
最終更新: 2012-04-11
使用頻度: 7
品質:
dozele repetate, mai mari decât doza recomandată, sunt asociate cu mielosupresie crescută, inclusiv leucopenie, anemie şi trombocitopenie.
higher than recommended repeat doses are associated with increased myelosuppression including leukopenia, anaemia and thrombocytopenia.
最終更新: 2017-04-26
使用頻度: 1
品質:
pacienţii trataţi cu pixuvri pot prezenta mielosupresie (neutropenie, leucopenie, anemie, trombocitopenie şi limfopenie), neutropenia fiind manifestarea predominantă.
patients treated with pixuvri are likely to experience myelosuppression (neutropenia, leukopenia, anaemia, thrombocytopenia, and lymphopenia) with the predominant manifestation being neutropenia.
最終更新: 2017-04-26
使用頻度: 1
品質:
de obicei mielosupresia este forma de toxicitate care impune limitarea dozei.
myelosuppression is usually the dose-limiting toxicity.
最終更新: 2017-04-26
使用頻度: 4
品質: